Immunology of tuberculosis

Annual Review of Immunology

Volumn 19, Issue , 2001, Pages 93-129

  Flynn, J L ^a   Chan, J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Cytokine; Macrophage; Mycobacterium tuberculosis; T lymphocytes

Indexed keywords

CD1 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTATION; CELL SPECIFICITY; CELLULAR IMMUNITY; EFFECTOR CELL; HOST RESISTANCE; HUMAN; LYSOSOME; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

ANIMALS; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; NITROGEN OXIDES; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTE SUBSETS; TUBERCULOMA; TUBERCULOSIS;

EID: 0035064072     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.19.1.93     Document Type: Review

References (217)

1. Latent and reactivation tuberculosis
2. Studies on the mechanism of immunity in tuberculosis. The fate of tubercle bacilli ingested by mononuclear phagocytes derived from normal and immunized animals
3. The multiplication of tubercle bacilli within normal phagocytes in tissue cultures
4. The influence of immunologically committed lymphoid cells on macrophage activation in vivo
5. Immune mechanisms of protection
6. Killing of Mycobacterium microti by immunologically activated macrophages
7. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: Comparison of the effects of recombinant gamma interferon on human monocytes and murine peritoneal macrophages
8. Mycobacterial growth inhibition by interferon-g activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis
9. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor
10. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages
11. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria
12. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria
13. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages
14. The role of vitamin D in tuberculosis
15. Killing of Mycobacterium tuberculosis within human monocytes: Activation by cytokines and calcitriol
16. The immunobiology of vitamin D
17. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line
18. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: Requirement for IFN-gamma and primed lymphocytes
19. Functions of lysosomes
20. The discovery of lysosomes
21. Trafficking of lysosomal enzymes
22. Acidification of the endocytic and exocytic pathways
23. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
24. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus
25. Biogenesis of phagolysosomes: The 'kiss and run' hypothesis
26. The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages
27. Regulation of phagosomal acidification. Differential targeting of Na+/H+ exchangers, Na+/K+-ATPases, and vacuolar-type H+-atpases
28. Phagosomal maturation, acidification, and inhibition of bacterial growth in nonphagocytic cells transfected with FcgRIIA receptors
29. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes
30. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria
31. Mycobacterium and Leishmania: Stowaways in the endosomal network
32. Mycobacterium tuberculosis phagosome
33. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host plasmalemma
34. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis
35. Sulfolipid from virulent tubercle bacilli
36. Sulfatides of Mycobacterium tuberculosis: The structure of the principal sulfatide (SL-1)
37. Ammonia inhibits phagosome-lysosome fusion in macrophages
38. Chemical inhibitors of phagosome-lysosome fusion in cultured macrophages also inhibit saltatory lysosomal movements. A combined microscopic and computer study
39. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited
40. The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guerin
41. Urease activity does not contribute dramatically to persistence of Mycobacterium bovis bacillus Calmette-Guerin
42. Glutamine synthetase of Mycobacterium tuberculosis: Extracellular release and characterization of its enzymatic activity
43. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets
44. Coat proteins and vesicle budding
45. Protein sorting by transport vesicles
46. GTP-binding proteins in intracellular transport
47. Rab GT-Pases in vesicular transport
48. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7
49. Mutant Rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment
50. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic
51. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase
52. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages
53. Coat protein on phagosomes involved in the intracellular survival of mycobacteria
54. Mechanisms of nitric oxide-related antimicrobial activity
55. Nitric oxide and macrophage function
56. Nitric oxide in Mycobacterium tuberculosis infection
57. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria
58. Identification of nitric oxide synthase as a protective locus against tuberculosis
59. Effects of aminoguanidine on latent murine tuberculosis
60. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis
61. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages
62. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
63. Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals
64. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages
65. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice
66. Transient loss of resistance to pulmonary tuberculosis in p47phox-/- mice
67. The role of the phagocytic respiratory burst in host defense against Mycobacterium tuberculosis
68. A conserved signaling pathway: The Drosophila toll-dorsal pathway
69. Function and activation of NF-kappa B in the immune system
70. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
71. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
72. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
73. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family
74. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
75. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
76. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
77. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
78. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
79. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
80. Functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lps gene: In vivo evidence for a dominant negative mutation
81. Drosophila host defense: Differential induction of antimicrobial peptide genes after infection by various classes of microorganisms
82. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages
83. Activation of human dendritic cells following infection with Mycobacterium tuberculosis
84. Ovalbumin (OVA) and Myocbacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper cells foward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia
85. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
86. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
87. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
88. Therapy of tuberculosis in mice by DNA vaccination
89. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis
90. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis
91. T Lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection
92. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
93. Early emergence of CD8+ T cells primed for production of Type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
94. Patterns of cytokine production by Mycobacterium-reactive human T-cell clones
95. Macrophages are a significant source of type 1 cytokines during mycobacterial infection
96. Induction of gamma-interferon production in human alveolar macrophages by Mycobacterium tuberculosis
97. Disseminated tuberculosis in IFN-γ gene-disrupted mice
98. An essential role for Interferon-γ in resistance to Mycobacterium tuberculosis infection
99. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
100. Absence of a prominent TH2 cytokine response in human tuberculosis
101. T cell cytokine responses in human infection with Mycobacterium tuberculosis
102. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1
103. Dichotomyofcytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis
104. Mice incapable of making IL-4 and IL-10 display normal resistance in infection with Mycobacterium tuberculosis
105. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection
106. In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granuloma
107. Tumor necrosis factor-α is required in the protective immune response against M. tuberculosis in mice
108. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
109. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide
110. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium
111. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
112. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: Synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas
113. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis
114. Mycobacteria, cytokines and antibiotics
115. Effect of cytokine modulation by thalidomide on the granomatous response in murine tuberculosis
116. Inhibition of interferon γ induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor
117. Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomized phase III trial
118. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA4 expression
119. TNF-α and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macorphages
120. T cell-derived IL-10 antagonizes macrophage function in mycobacteria infection
121. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses
122. Lethal tuberculosis in Interleukin-6-deficient mutant mice
123. In vitro restoration of T cell responses in tuberculosis and augmentation of moncyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta
124. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculosis granulomatous lung lesions
125. Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis
126. Regulation of human CD4+ αβ TCR+ and γδ TCR+ T cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β
127. Macrophage deactivation factor and TFG-β inhibition of macrophage nitrogen oxide synthesis by IFN-γ
128. CD8+ cytotoxic T lymphocytes from lungs of M. tuberculosis infected mice express perforin in vivo and lyse infected macrophages
129. Increase in gamma interferon-secreting CD8+, as well as CD4+ T cells in lungs following aerosol infection with Mycobacterium tuberculosis
130. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
131. Lymphocyte subsets in granulomas of human tuberculosis: An in situ immunofluorescence study using monoclonal antibodies
132. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt2+ T cells
133. Adoptive protection of the Mycobacteria tuberculosis-infected lung
134. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy
135. Protection against Mycobacterium tuberculosis infection by CD8 T cells requires production of gamma interferon
136. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis
137. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
138. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of IFN-γ and NOS2
139. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis
140. The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity
141. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses
142. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
143. Mycobacterium tuberculosis aerogenic challenge infections in B cell-deficient mice
144. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
145. Infection of B cell deficient mice with CDC1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology
146. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α
147. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis
148. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis
149. Differential effects of cytolytic T cell subsets on intracellular infection
150. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis
151. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection
152. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers
153. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages
154. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis BCG involves class II transactivator and depends on the Nramp1 gene
155. Down-regulation of CD1 on antigen presenting cells by infection with Mycobacterium tuberculosis
156. Pathogenesis of Tuberculosis: Interaction of Mycobacterium tuberculosis with macrophages
157. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
158. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice
159. Mycobacteria-reactive Lyt-2+ T cell lines
160. Protection against tuberculosis by passive transfer with T-cell clones recognizing mycobacterial heat shock protein 65
161. Specificity of CD8+ T cells from subunit vaccinated or infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis
162. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis infection
163. CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19kDa lipoprotein
164. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen presenting cells
165. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
166. Antimicrobial activity of MHC class I restricted CD8+ T cells in human tuberculosis
167. Mycobacterial infection of macrophages results in membrane-permeable phagosomes
168. Activation of human CD8+ αβ TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen processing pathway
169. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
170. Evidence for human CD4+ T cells in the CD1-restricted repertoire: Derivation of mycobacteria-reactive T cells from leprosy lesions
171. Recognition of a lipid antigen by CD1-restricted αβ + T cells
172. CD1-restricted T cell recognition of microbial lipoglycan antigens
173. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells
174. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection
175. The tyrosine containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens
176. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs
177. Separate pathways for antigen presentation by CD1 molecules
178. Intersection of Group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells
179. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens
180. Trafficking and release of mycobacterial lipids from infected macrophages
181. CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen
182. CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity
183. Conservation of a CD 1 multigene family in the guinea pig
184. H2-M3-restricted T cells in bacterial infection: Rapid primary but diminished memory responses
185. CD8+ T lymphocytes in intracellular microbial infections
186. Immunity to intracellular bacteria
187. An antimicrobial activity of cytotoxic T cells mediated by granulysin
188. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin-or granzyme-mediated cytolytic mechanisms
189. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice
190. A role for perforin in downregulating T-cell responses during chronic viral infection
191. Adequate expression of protective immunity in the absence of granuloma formation in Myocbaterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene
192. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
193. The role of chemokine receptors in primary, effector, and memory immune responses
194. Multistep navigation and combinatorial control of leukocyte chemotaxis
195. Chemokines: Chemotactic cytokines that mediate inflammation
196. Human chemokined: An update
197. Cytokine/chemokine cascades in immunity to tuberculosis
198. Chemokine response in mice infected with Mycobacterium tuberculosis
199. High level monocyte chemoattractant protein-1 expression in transgenic mice increase their susceptibility to intracellular pathogens
200. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
201. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis
202. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients
203. Production of monocyte chemoattractant protein 1 in tuberculosis patients
204. Expression of CCR5 is increasedin human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection
205. The effect of mycobacterial infection on virus load and disease progression in Simian Immunodeficiency Virus-infected rhesus monkeys
206. Differential monocyte chemoattractant protein-1 and CCR2 expression by murine lung fibroblasts derived from Th1 and Th2 type pulmonary granuloma models
207. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: Analysis of cellular recruitment and cytokine responses
208. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
209. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
210. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation
211. TNF-alpha inhibits HIV-1-replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression
212. In vitro and in vivo dependency of chemokine generation on C5a and TNF-α
213. Differential regulation of the expression of cytokine-induced neutrophil chemoattractant by mouse macrophages
214. Monocyte chemotactic factors released from type II pneumocyte-like cells in respone to TNF-a and IL-1 a
215. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV) seropositivie and HIV-seronegative patients with tuberculosis: A possible role for mycobacterial lipoarabinomannan
216. Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis